Vistin Pharma - Call Transcript 2023

Vistin Pharma ASA: Invitation to Q4 2022 conference call

Oslo, Norway, 10 February 2023

Vistin Pharma ASA will release its fourth quarter and preliminary 2022 results

on Friday 17(th) of February 2023. Vistin Pharma will host a conference call for

all shareholders and interested parties at the same day; Friday 17(th) of

February at 08:30 CET. There will be a Q&A session following the management

discussion.

The conference call will be held in English.

The fourth quarter conference call will be available via web and audio through

the following access points:

Webcast:

https://edge.media-server.com/mmc/p/cuz2jc4e

Telephone conference (online registration):

https://register.vevent.com/register/BI68307a0a256a4fd8b13cef5199b3578c

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant